Literature DB >> 12960195

Cancer therapy with Auger electrons: are we almost there?

Amin I Kassis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12960195

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  16 in total

1.  Computational modeling of cellular effects post-irradiation with low- and high-let particles and different absorbed doses.

Authors:  Adriana Alexandre S Tavares; João Manuel R S Tavares
Journal:  Dose Response       Date:  2012-03-19       Impact factor: 2.658

Review 2.  Planning for intracavitary anti-EGFR radionuclide therapy of gliomas. Literature review and data on EGFR expression.

Authors:  J Carlsson; Z P Ren; K Wester; A L Sundberg; N E Heldin; G Hesselager; M Persson; L Gedda; V Tolmachev; H Lundqvist; E Blomquist; M Nistér
Journal:  J Neurooncol       Date:  2006-03       Impact factor: 4.130

3.  Bystander effect in tumor cells produced by Iodine-125 labeled human lymphocytes.

Authors:  Omar Mamlouk; Pichumani Balagurumoorthy; Ketai Wang; S James Adelstein; Amin I Kassis
Journal:  Int J Radiat Biol       Date:  2012-07-09       Impact factor: 2.694

4.  Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen.

Authors:  Il Minn; Ying Chen; Ana P Kiess; Robert Hobbs; George Sgouros; Ronnie C Mease; Mrudula Pullambhatla; Colette J Shen; Catherine A Foss; Martin G Pomper
Journal:  J Nucl Med       Date:  2015-07-16       Impact factor: 10.057

5.  Anti-tumor effect of 125I-UdR in combination with Egr-1 promoter-based IFNγ gene therapy in vivo.

Authors:  Wei Yang; Jing-Guo Zhao; Xiu-Yi Li; Shou-Liang Gong; Jian-Ping Cao
Journal:  Radiat Environ Biophys       Date:  2010-07-03       Impact factor: 1.925

6.  Targeted Brain Tumor Radiotherapy Using an Auger Emitter.

Authors:  Giacomo Pirovano; Stephen A Jannetti; Lukas M Carter; Ahmad Sadique; Susanne Kossatz; Navjot Guru; Paula Demétrio De Souza França; Masatomo Maeda; Brian M Zeglis; Jason S Lewis; John L Humm; Thomas Reiner
Journal:  Clin Cancer Res       Date:  2020-02-17       Impact factor: 12.531

7.  Trastuzumab labeled to high specific activity with ¹¹¹In by conjugation to G4 PAMAM dendrimers derivatized with multiple DTPA chelators exhibits increased cytotoxic potency on HER2-positive breast cancer cells.

Authors:  Conrad Chan; Zhongli Cai; Raymond M Reilly
Journal:  Pharm Res       Date:  2013-04-25       Impact factor: 4.200

8.  Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis.

Authors:  Lore Santoro; Samir Boutaleb; Véronique Garambois; Caroline Bascoul-Mollevi; Vincent Boudousq; Pierre-Olivier Kotzki; Monique Pèlegrin; Isabelle Navarro-Teulon; André Pèlegrin; Jean-Pierre Pouget
Journal:  J Nucl Med       Date:  2009-11-12       Impact factor: 10.057

9.  Improved radiosynthesis of 123I-MAPi, an auger theranostic agent.

Authors:  Thomas C Wilson; Stephen A Jannetti; Navjot Guru; Nagavarakishore Pillarsetty; Thomas Reiner; Giacomo Pirovano
Journal:  Int J Radiat Biol       Date:  2020-07-02       Impact factor: 2.694

Review 10.  Auger: The future of precision medicine.

Authors:  Giacomo Pirovano; Thomas C Wilson; Thomas Reiner
Journal:  Nucl Med Biol       Date:  2021-03-19       Impact factor: 2.408
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.